nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—ALOX5—Montelukast—allergic rhinitis	0.569	1	CbGbCtD
Minocycline—CYCS—exocrine gland—allergic rhinitis	0.0131	0.0722	CbGeAlD
Minocycline—CASP3—exocrine gland—allergic rhinitis	0.0112	0.0618	CbGeAlD
Minocycline—IL1B—IL1 and megakaryotyces in obesity—TLR1—allergic rhinitis	0.00788	0.0332	CbGpPWpGaD
Minocycline—CASP1—respiratory system—allergic rhinitis	0.00706	0.039	CbGeAlD
Minocycline—CYCS—respiratory system—allergic rhinitis	0.0068	0.0376	CbGeAlD
Minocycline—CASP1—Interleukin-1 processing—NFKB1—allergic rhinitis	0.00645	0.0272	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL15—allergic rhinitis	0.00636	0.0268	CbGpPWpGaD
Minocycline—CYCS—eye—allergic rhinitis	0.00621	0.0343	CbGeAlD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—TLR1—allergic rhinitis	0.00604	0.0255	CbGpPWpGaD
Minocycline—CASP1—epithelium—allergic rhinitis	0.0059	0.0326	CbGeAlD
Minocycline—CASP3—respiratory system—allergic rhinitis	0.00582	0.0322	CbGeAlD
Minocycline—CASP1—bronchus—allergic rhinitis	0.00581	0.0321	CbGeAlD
Minocycline—CYCS—epithelium—allergic rhinitis	0.00568	0.0314	CbGeAlD
Minocycline—CASP1—skin of body—allergic rhinitis	0.00562	0.031	CbGeAlD
Minocycline—CYCS—bronchus—allergic rhinitis	0.0056	0.0309	CbGeAlD
Minocycline—CYCS—skin of body—allergic rhinitis	0.00541	0.0299	CbGeAlD
Minocycline—CASP3—eye—allergic rhinitis	0.00532	0.0294	CbGeAlD
Minocycline—CASP1—trachea—allergic rhinitis	0.00522	0.0288	CbGeAlD
Minocycline—CASP3—epithelium—allergic rhinitis	0.00487	0.0269	CbGeAlD
Minocycline—CASP3—bronchus—allergic rhinitis	0.00479	0.0265	CbGeAlD
Minocycline—IL1B—respiratory system—allergic rhinitis	0.00465	0.0257	CbGeAlD
Minocycline—CASP3—skin of body—allergic rhinitis	0.00463	0.0256	CbGeAlD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL13—allergic rhinitis	0.00447	0.0189	CbGpPWpGaD
Minocycline—CASP3—trachea—allergic rhinitis	0.0043	0.0238	CbGeAlD
Minocycline—IL1B—eye—allergic rhinitis	0.00425	0.0235	CbGeAlD
Minocycline—IL1B—IL27-mediated signaling events—IL17A—allergic rhinitis	0.00424	0.0179	CbGpPWpGaD
Minocycline—IL1B—Interleukin-1 processing—NFKB1—allergic rhinitis	0.00403	0.017	CbGpPWpGaD
Minocycline—IL1B—epithelium—allergic rhinitis	0.00389	0.0215	CbGeAlD
Minocycline—MMP9—respiratory system—allergic rhinitis	0.00388	0.0214	CbGeAlD
Minocycline—IL1B—bronchus—allergic rhinitis	0.00383	0.0212	CbGeAlD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL5—allergic rhinitis	0.00383	0.0161	CbGpPWpGaD
Minocycline—VEGFA—bronchus—allergic rhinitis	0.00377	0.0208	CbGeAlD
Minocycline—CASP1—lung—allergic rhinitis	0.00375	0.0207	CbGeAlD
Minocycline—IL1B—skin of body—allergic rhinitis	0.0037	0.0204	CbGeAlD
Minocycline—CYCS—lung—allergic rhinitis	0.00361	0.0199	CbGeAlD
Minocycline—MMP9—eye—allergic rhinitis	0.00354	0.0196	CbGeAlD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.00353	0.0149	CbGpPWpGaD
Minocycline—VEGFA—trachea—allergic rhinitis	0.00338	0.0187	CbGeAlD
Minocycline—MMP9—epithelium—allergic rhinitis	0.00324	0.0179	CbGeAlD
Minocycline—IL1B—IL23-mediated signaling events—IL17A—allergic rhinitis	0.0032	0.0135	CbGpPWpGaD
Minocycline—CASP3—lung—allergic rhinitis	0.00309	0.0171	CbGeAlD
Minocycline—MMP9—skin of body—allergic rhinitis	0.00308	0.017	CbGeAlD
Minocycline—ALOX5—respiratory system—allergic rhinitis	0.00307	0.0169	CbGeAlD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL10—allergic rhinitis	0.0028	0.0118	CbGpPWpGaD
Minocycline—IL1B—Hematopoietic Stem Cell Differentiation—IL5—allergic rhinitis	0.00279	0.0118	CbGpPWpGaD
Minocycline—CASP1—Inflammasomes—NFKB1—allergic rhinitis	0.00279	0.0117	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL4—allergic rhinitis	0.00272	0.0115	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.00258	0.0109	CbGpPWpGaD
Minocycline—ALOX5—bronchus—allergic rhinitis	0.00252	0.0139	CbGeAlD
Minocycline—CYCS—Apoptosis Modulation by HSP70—NFKB1—allergic rhinitis	0.00248	0.0105	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.00247	0.0104	CbGpPWpGaD
Minocycline—IL1B—lung—allergic rhinitis	0.00247	0.0136	CbGeAlD
Minocycline—CASP3—Allograft Rejection—FOXP3—allergic rhinitis	0.00245	0.0103	CbGpPWpGaD
Minocycline—VEGFA—lung—allergic rhinitis	0.00243	0.0134	CbGeAlD
Minocycline—IL1B—IL1 and megakaryotyces in obesity—ICAM1—allergic rhinitis	0.00238	0.01	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-G—allergic rhinitis	0.00222	0.00937	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—FOXP3—allergic rhinitis	0.00222	0.00934	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL13—allergic rhinitis	0.00209	0.00883	CbGpPWpGaD
Minocycline—MMP9—lung—allergic rhinitis	0.00206	0.0114	CbGeAlD
Minocycline—CASP1—Signaling by Interleukins—IL5—allergic rhinitis	0.00202	0.00852	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—SMAD3—allergic rhinitis	0.00201	0.00849	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-G—allergic rhinitis	0.00201	0.00848	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation by HSP70—NFKB1—allergic rhinitis	0.002	0.00845	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.00193	0.00815	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL17A—allergic rhinitis	0.00193	0.00812	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL13—allergic rhinitis	0.00189	0.00799	CbGpPWpGaD
Minocycline—SLC22A8—eye—allergic rhinitis	0.00189	0.0105	CbGeAlD
Minocycline—MMP9—Osteopontin Signaling—NFKB1—allergic rhinitis	0.00188	0.00795	CbGpPWpGaD
Minocycline—CYCS—Ketotifen—Loratadine—allergic rhinitis	0.00187	0.142	CbGdCrCtD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.00184	0.00775	CbGpPWpGaD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—ICAM1—allergic rhinitis	0.00182	0.00768	CbGpPWpGaD
Minocycline—CASP1—IL1-mediated signaling events—NFKB1—allergic rhinitis	0.00182	0.00768	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.0018	0.00761	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL5—allergic rhinitis	0.00179	0.00755	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL17A—allergic rhinitis	0.00174	0.00735	CbGpPWpGaD
Minocycline—IL1B—Type II interferon signaling (IFNG)—ICAM1—allergic rhinitis	0.00168	0.00709	CbGpPWpGaD
Minocycline—ALOX5—lung—allergic rhinitis	0.00163	0.00899	CbGeAlD
Minocycline—IL1B—Allograft Rejection—IL5—allergic rhinitis	0.00162	0.00684	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—PFN2—allergic rhinitis	0.00161	0.00678	CbGpPWpGaD
Minocycline—CYCS—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKB1—allergic rhinitis	0.0016	0.00673	CbGpPWpGaD
Minocycline—CYCS—Ketotifen—Cyproheptadine—allergic rhinitis	0.00159	0.121	CbGdCrCtD
Minocycline—IL1B—Cytokines and Inflammatory Response—CD4—allergic rhinitis	0.00159	0.0067	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—IL17A—allergic rhinitis	0.00157	0.00663	CbGpPWpGaD
Minocycline—IL1B—IL1 and megakaryotyces in obesity—NFKB1—allergic rhinitis	0.0015	0.00634	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—FOXP3—allergic rhinitis	0.00147	0.00622	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.00146	0.00614	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—ICAM1—allergic rhinitis	0.00145	0.0061	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—IL4—allergic rhinitis	0.00144	0.00606	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—PFN2—allergic rhinitis	0.0014	0.00589	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.00139	0.00585	CbGpPWpGaD
Minocycline—VEGFA—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.00139	0.00584	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL5—allergic rhinitis	0.00137	0.00578	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-G—allergic rhinitis	0.00134	0.00565	CbGpPWpGaD
Minocycline—CASP1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NFKB1—allergic rhinitis	0.00134	0.00564	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IL4—allergic rhinitis	0.00133	0.00561	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL10—allergic rhinitis	0.00131	0.00552	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.0013	0.00548	CbGpPWpGaD
Minocycline—CASP3—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKB1—allergic rhinitis	0.00129	0.00543	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL4—allergic rhinitis	0.00127	0.00537	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL5—allergic rhinitis	0.00126	0.00532	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL13—allergic rhinitis	0.00126	0.00532	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.00126	0.00529	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—CD4—allergic rhinitis	0.00124	0.00521	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.00121	0.00512	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MS4A2—allergic rhinitis	0.00121	0.00512	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL10—allergic rhinitis	0.00119	0.005	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—NFKB1—allergic rhinitis	0.00118	0.00499	CbGpPWpGaD
Minocycline—IL1B—IL27-mediated signaling events—TGFB1—allergic rhinitis	0.00118	0.00496	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.00117	0.00493	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL17A—allergic rhinitis	0.00116	0.0049	CbGpPWpGaD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—NFKB1—allergic rhinitis	0.00115	0.00487	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL4—allergic rhinitis	0.00115	0.00486	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PFN2—allergic rhinitis	0.00115	0.00484	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—TGFB1—allergic rhinitis	0.00114	0.00481	CbGpPWpGaD
Minocycline—IL1B—IL1-mediated signaling events—NFKB1—allergic rhinitis	0.00114	0.0048	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.00112	0.00471	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.0011	0.00464	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL5—allergic rhinitis	0.00108	0.00455	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—NFKB1—allergic rhinitis	0.00106	0.00449	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.00106	0.00448	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—ICAM1—allergic rhinitis	0.00106	0.00446	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.00101	0.00427	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.00101	0.00426	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL10—allergic rhinitis	0.001	0.00422	CbGpPWpGaD
Minocycline—CASP3—Syndecan-2-mediated signaling events—TGFB1—allergic rhinitis	0.001	0.00422	CbGpPWpGaD
Minocycline—IL1B—Interleukin-1 signaling—NFKB1—allergic rhinitis	0.001	0.00422	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PFN2—allergic rhinitis	0.000996	0.0042	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL4—allergic rhinitis	0.000974	0.00411	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000943	0.00397	CbGpPWpGaD
Minocycline—MMP9—Osteopontin-mediated events—NFKB1—allergic rhinitis	0.00094	0.00396	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL4—allergic rhinitis	0.000924	0.0039	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.000917	0.00387	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—NFKB1—allergic rhinitis	0.000917	0.00387	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.000909	0.00383	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—NFKB1—allergic rhinitis	0.000884	0.00373	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000877	0.0037	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—SMAD3—allergic rhinitis	0.000875	0.00369	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.00084	0.00354	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD4—allergic rhinitis	0.000839	0.00354	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL4—allergic rhinitis	0.000837	0.00353	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000836	0.00352	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—NFKB1—allergic rhinitis	0.000829	0.00349	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	0.000823	0.00347	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL10—allergic rhinitis	0.000789	0.00333	CbGpPWpGaD
Minocycline—VEGFA—Glypican 1 network—TGFB1—allergic rhinitis	0.000783	0.0033	CbGpPWpGaD
Minocycline—IL1B—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.000775	0.00327	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL4—allergic rhinitis	0.000768	0.00324	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.00076	0.0032	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000758	0.0032	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—NFKB1—allergic rhinitis	0.000756	0.00319	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000749	0.00316	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000745	0.00314	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.00074	0.00312	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.000737	0.00311	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000734	0.0031	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000732	0.00309	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000731	0.00308	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.00073	0.00308	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—NFKB1—allergic rhinitis	0.000723	0.00305	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000723	0.00305	CbGpPWpGaD
Minocycline—IL1B—Methylprednisolone—Flunisolide—allergic rhinitis	0.000717	0.0543	CbGdCrCtD
Minocycline—CYCS—Apoptosis Modulation and Signaling—NFKB1—allergic rhinitis	0.000709	0.00299	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000709	0.00299	CbGpPWpGaD
Minocycline—CASP1—Immune System—MS4A2—allergic rhinitis	0.000707	0.00298	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000688	0.0029	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000674	0.00284	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—NFKB1—allergic rhinitis	0.00067	0.00282	CbGpPWpGaD
Minocycline—MMP9—Syndecan-1-mediated signaling events—TGFB1—allergic rhinitis	0.000665	0.00281	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000665	0.0028	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL4—allergic rhinitis	0.000642	0.00271	CbGpPWpGaD
Minocycline—CASP3—p75 NTR receptor-mediated signalling—NFKB1—allergic rhinitis	0.000622	0.00262	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—allergic rhinitis	0.000614	0.00259	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—NFKB1—allergic rhinitis	0.00061	0.00257	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD4—allergic rhinitis	0.000607	0.00256	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000605	0.00255	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000595	0.00251	CbGpPWpGaD
Minocycline—CYCS—Clemastine—Cetirizine—allergic rhinitis	0.000591	0.0448	CbGdCrCtD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000589	0.00248	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—NFKB1—allergic rhinitis	0.000572	0.00241	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	0.000567	0.00239	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	0.000567	0.00239	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TGFB1—allergic rhinitis	0.000534	0.00225	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000533	0.00225	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.000532	0.00224	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000526	0.00222	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—NFKB1—allergic rhinitis	0.000523	0.0022	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.000514	0.00217	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—ICAM1—allergic rhinitis	0.00051	0.00215	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000507	0.00214	CbGpPWpGaD
Minocycline—CYCS—Protriptyline—Cyproheptadine—allergic rhinitis	0.000497	0.0376	CbGdCrCtD
Minocycline—MMP9—CXCR4-mediated signaling events—CD4—allergic rhinitis	0.000492	0.00207	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TGFB1—allergic rhinitis	0.000483	0.00204	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—TGFB1—allergic rhinitis	0.000479	0.00202	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000474	0.002	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000473	0.00199	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	0.000473	0.00199	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000458	0.00193	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000456	0.00192	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000452	0.0019	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000451	0.0019	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.000449	0.00189	CbGpPWpGaD
Minocycline—CYCS—Nefazodone—Cetirizine—allergic rhinitis	0.000448	0.0339	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Flunisolide—allergic rhinitis	0.000444	0.0336	CbGdCrCtD
Minocycline—IL1B—Immune System—MS4A2—allergic rhinitis	0.000442	0.00186	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—TGFB1—allergic rhinitis	0.000439	0.00185	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—TGFB1—allergic rhinitis	0.000435	0.00184	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000423	0.00178	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TGFB1—allergic rhinitis	0.000408	0.00172	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000396	0.00167	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000387	0.00163	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—ICAM1—allergic rhinitis	0.000386	0.00163	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	0.000385	0.00162	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-G—allergic rhinitis	0.000382	0.00161	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.000382	0.00161	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—TGFB1—allergic rhinitis	0.000381	0.00161	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.000372	0.00157	CbGpPWpGaD
Minocycline—IL1B—Methylprednisolone—Hydrocortisone—allergic rhinitis	0.000372	0.0281	CbGdCrCtD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000369	0.00156	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000351	0.00148	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.00035	0.00148	CbGpPWpGaD
Minocycline—IL1B—Methylprednisolone—Dexamethasone—allergic rhinitis	0.000345	0.0261	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Betamethasone—allergic rhinitis	0.000345	0.0261	CbGdCrCtD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—NFKB1—allergic rhinitis	0.000338	0.00143	CbGpPWpGaD
Minocycline—IL1B—Methylprednisolone—Triamcinolone—allergic rhinitis	0.000337	0.0255	CbGdCrCtD
Minocycline—CASP1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000337	0.00142	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.000337	0.00142	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000333	0.0014	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TGFB1—allergic rhinitis	0.000322	0.00136	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB1—allergic rhinitis	0.000318	0.00134	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000317	0.00134	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000316	0.00133	CbGpPWpGaD
Minocycline—IL1B—Methylprednisolone—Prednisolone—allergic rhinitis	0.000313	0.0237	CbGdCrCtD
Minocycline—CYCS—Quetiapine—Cetirizine—allergic rhinitis	0.000313	0.0237	CbGdCrCtD
Minocycline—CASP1—Immune System—IL5—allergic rhinitis	0.000308	0.0013	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	0.000303	0.00128	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—NFKB1—allergic rhinitis	0.000302	0.00128	CbGpPWpGaD
Minocycline—IL1B—Budesonide—Flunisolide—allergic rhinitis	0.000297	0.0225	CbGdCrCtD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000292	0.00123	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ADIPOQ—allergic rhinitis	0.000278	0.00117	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000269	0.00113	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTGDR2—allergic rhinitis	0.000269	0.00113	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—ICAM1—allergic rhinitis	0.000268	0.00113	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000264	0.00111	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000263	0.00111	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL5—allergic rhinitis	0.000244	0.00103	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ADIPOQ—allergic rhinitis	0.000241	0.00102	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-G—allergic rhinitis	0.000239	0.00101	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DQB1—allergic rhinitis	0.000238	0.00101	CbGpPWpGaD
Minocycline—IL1B—Fluorometholone—Hydrocortisone—allergic rhinitis	0.00023	0.0174	CbGdCrCtD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.00023	0.00097	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NFKB1—allergic rhinitis	0.000229	0.000965	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.000224	0.000945	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—allergic rhinitis	0.000219	0.000926	CbGpPWpGaD
Minocycline—IL1B—Fluorometholone—Methylprednisolone—allergic rhinitis	0.000217	0.0165	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Dexamethasone—allergic rhinitis	0.000214	0.0162	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Betamethasone—allergic rhinitis	0.000214	0.0162	CbGdCrCtD
Minocycline—IL1B—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000211	0.000889	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000211	0.000888	CbGpPWpGaD
Minocycline—IL1B—Fluorometholone—Triamcinolone—allergic rhinitis	0.000209	0.0158	CbGdCrCtD
Minocycline—CYCS—Alimemazine—Diphenhydramine—allergic rhinitis	0.000207	0.0156	CbGdCrCtD
Minocycline—CASP3—Signaling Pathways—CCL11—allergic rhinitis	0.000203	0.000858	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—allergic rhinitis	0.000203	0.000857	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—SMAD3—allergic rhinitis	0.000202	0.000851	CbGpPWpGaD
Minocycline—IL1B—Fluorometholone—Prednisolone—allergic rhinitis	0.000194	0.0147	CbGdCrCtD
Minocycline—IL1B—Immune System—IL5—allergic rhinitis	0.000192	0.000811	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000191	0.000804	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NFKB1—allergic rhinitis	0.000189	0.000797	CbGpPWpGaD
Minocycline—VEGFA—Carbinoxamine—Diphenhydramine—allergic rhinitis	0.000187	0.0141	CbGdCrCtD
Minocycline—MMP9—Signaling Pathways—PTGDR2—allergic rhinitis	0.000186	0.000786	CbGpPWpGaD
Minocycline—IL1B—Dexamethasone—Flunisolide—allergic rhinitis	0.000181	0.0137	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Flunisolide—allergic rhinitis	0.000181	0.0137	CbGdCrCtD
Minocycline—VEGFA—Developmental Biology—SMAD3—allergic rhinitis	0.000175	0.000739	CbGpPWpGaD
Minocycline—CASP1—Immune System—ICAM1—allergic rhinitis	0.000174	0.000734	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTGDR2—allergic rhinitis	0.000162	0.000682	CbGpPWpGaD
Minocycline—CYCS—Clomifene—Diphenhydramine—allergic rhinitis	0.000159	0.012	CbGdCrCtD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000159	0.000669	CbGpPWpGaD
Minocycline—IL1B—Budesonide—Hydrocortisone—allergic rhinitis	0.000154	0.0116	CbGdCrCtD
Minocycline—IL1B—Immune System—HLA-DQB1—allergic rhinitis	0.000149	0.000628	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TAC1—allergic rhinitis	0.000148	0.000623	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—NFKB1—allergic rhinitis	0.000147	0.00062	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000146	0.000617	CbGpPWpGaD
Minocycline—IL1B—Budesonide—Methylprednisolone—allergic rhinitis	0.000145	0.011	CbGdCrCtD
Minocycline—IL1B—Budesonide—Betamethasone—allergic rhinitis	0.000143	0.0108	CbGdCrCtD
Minocycline—IL1B—Budesonide—Dexamethasone—allergic rhinitis	0.000143	0.0108	CbGdCrCtD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000141	0.000596	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL11—allergic rhinitis	0.000141	0.000596	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—allergic rhinitis	0.000141	0.000595	CbGpPWpGaD
Minocycline—IL1B—Budesonide—Triamcinolone—allergic rhinitis	0.00014	0.0106	CbGdCrCtD
Minocycline—CASP3—Signaling Pathways—IL5—allergic rhinitis	0.000137	0.00058	CbGpPWpGaD
Minocycline—IL1B—Budesonide—Prednisolone—allergic rhinitis	0.000129	0.00979	CbGdCrCtD
Minocycline—CASP1—Immune System—CD4—allergic rhinitis	0.000128	0.000539	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000127	0.000535	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL11—allergic rhinitis	0.000123	0.000517	CbGpPWpGaD
Minocycline—CASP1—Immune System—NFKB1—allergic rhinitis	0.00011	0.000464	CbGpPWpGaD
Minocycline—IL1B—Immune System—ICAM1—allergic rhinitis	0.000109	0.000458	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NFKB1—allergic rhinitis	0.000103	0.000433	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TAC1—allergic rhinitis	0.000103	0.000433	CbGpPWpGaD
Minocycline—CYCS—Tamoxifen—Diphenhydramine—allergic rhinitis	0.000102	0.00772	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Flunisolide—allergic rhinitis	9.69e-05	0.00733	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Flunisolide—allergic rhinitis	9.69e-05	0.00733	CbGdCrCtD
Minocycline—CASP3—Signaling Pathways—SMAD3—allergic rhinitis	9.67e-05	0.000408	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL5—allergic rhinitis	9.54e-05	0.000402	CbGpPWpGaD
Minocycline—IL1B—Betamethasone—Hydrocortisone—allergic rhinitis	9.41e-05	0.00712	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Hydrocortisone—allergic rhinitis	9.41e-05	0.00712	CbGdCrCtD
Minocycline—VEGFA—Developmental Biology—NFKB1—allergic rhinitis	8.91e-05	0.000376	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TAC1—allergic rhinitis	8.91e-05	0.000376	CbGpPWpGaD
Minocycline—IL1B—Betamethasone—Methylprednisolone—allergic rhinitis	8.88e-05	0.00672	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Methylprednisolone—allergic rhinitis	8.88e-05	0.00672	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Betamethasone—allergic rhinitis	8.74e-05	0.00662	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Dexamethasone—allergic rhinitis	8.74e-05	0.00662	CbGdCrCtD
Minocycline—MMP9—Developmental Biology—TGFB1—allergic rhinitis	8.55e-05	0.000361	CbGpPWpGaD
Minocycline—IL1B—Betamethasone—Triamcinolone—allergic rhinitis	8.54e-05	0.00646	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Triamcinolone—allergic rhinitis	8.54e-05	0.00646	CbGdCrCtD
Minocycline—VEGFA—Signaling Pathways—IL5—allergic rhinitis	8.28e-05	0.000349	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—allergic rhinitis	7.99e-05	0.000337	CbGpPWpGaD
Minocycline—IL1B—Betamethasone—Prednisolone—allergic rhinitis	7.91e-05	0.00599	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisolone—allergic rhinitis	7.91e-05	0.00599	CbGdCrCtD
Minocycline—VEGFA—Developmental Biology—TGFB1—allergic rhinitis	7.42e-05	0.000313	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—allergic rhinitis	7.28e-05	0.000307	CbGpPWpGaD
Minocycline—IL1B—Immune System—NFKB1—allergic rhinitis	6.88e-05	0.00029	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMAD3—allergic rhinitis	6.72e-05	0.000283	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMAD3—allergic rhinitis	5.83e-05	0.000246	CbGpPWpGaD
Minocycline—VEGFA—Dexamethasone—Hydrocortisone—allergic rhinitis	5.03e-05	0.0038	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Hydrocortisone—allergic rhinitis	5.03e-05	0.0038	CbGdCrCtD
Minocycline—CASP3—Signaling Pathways—NFKB1—allergic rhinitis	4.92e-05	0.000207	CbGpPWpGaD
Minocycline—CYCS—Levonorgestrel—Hydrocortisone—allergic rhinitis	4.8e-05	0.00363	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Methylprednisolone—allergic rhinitis	4.74e-05	0.00359	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Methylprednisolone—allergic rhinitis	4.74e-05	0.00359	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Betamethasone—allergic rhinitis	4.67e-05	0.00353	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Dexamethasone—allergic rhinitis	4.67e-05	0.00353	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Triamcinolone—allergic rhinitis	4.56e-05	0.00345	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Triamcinolone—allergic rhinitis	4.56e-05	0.00345	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Prednisolone—allergic rhinitis	4.22e-05	0.0032	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisolone—allergic rhinitis	4.22e-05	0.0032	CbGdCrCtD
Minocycline—CASP3—Signaling Pathways—TGFB1—allergic rhinitis	4.1e-05	0.000173	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NFKB1—allergic rhinitis	3.41e-05	0.000144	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NFKB1—allergic rhinitis	2.96e-05	0.000125	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—allergic rhinitis	2.84e-05	0.00012	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—allergic rhinitis	2.47e-05	0.000104	CbGpPWpGaD
